Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | GRK2 | P25098 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1547671 | 0.92 | KDM4E (0.48) | MAPTCA1CA2POLBTDP1 | |
| SCHEMBL566263 | 0.91 | CA1 (0.41) | MAPTCA1CA2POLBTDP1 | |
| SCHEMBL10155856 | 0.90 | CA1 (0.43) | MAPTCA1CA2POLBTDP1 | |
| SCHEMBL1547589 | 0.89 | CNR1 (0.46) | MAPTCA1CA2NPC1RAB9A | |
| SCHEMBL1611856 | 0.89 | MEN1 (0.42) | TP53CA1CA2NPC1RAB9A | |
| SCHEMBL1575554 | 0.87 | TDP1 (0.44) | MAPTPOLBTDP1NPC1PAX8 | |
| SCHEMBL1547883 | 0.87 | BTK (0.42) | MAPTCA1CA2POLBTDP1 | |
| SCHEMBL1547718 | 0.87 | CYP3A4 (0.46) | MAPTPOLBTDP1NPC1RAB9A | |
| SCHEMBL13299347 | 0.87 | POLB (0.43) | MAPTPOLBTDP1NPC1PAX8 | |
| SCHEMBL1547872 | 0.86 | GRM4 (0.48) | NPC1RAB9AMEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785485-B2 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785485-B2 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-22 | — | — | US | disclosed |
| EP-2412240-B1 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL CO (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-2412239-B1 | Animal ectoparasite-controlling agent | SUMITOMO CHEMICAL CO (JP) | 2014-04-16 | — | — | EP | disclosed |
| EP-2647285-A2 | Pest control composition | Sumitomo Chemical Company, Limited (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-8507514-B2 | Hydrazide compound and use of the same in pest control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-13 | — | — | US | disclosed |
| EP-2601836-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2601837-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2601838-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Co., Ltd (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2601835-A1 | PEST CONTROL COMPOSITION | Sumitomo Chemical Co., Ltd (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-20130131115-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20120035218-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035218-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120029038-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120029038-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120029037-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120029037-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412239-A1 | Animal ectoparasite-controlling agent | Sumitomo Chemical Company, Limited (JP) | 2012-02-01 | — | — | EP | disclosed |
| EP-2412240-A1 | Animal ectoparasite-controlling agent | Sumitomo Chemical Company, Limited (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20110294840-A1 | HYDRAZIDE COMPOUND AND USE OF THE SAME IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131115-A1 | PEST CONTROL COMPOSITION | HRH2, HRH4, HRH1 | MAPT 4267/4885TP53 4408/4885CA1 1176/4885 |
| US-20120029037-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | H1-3, EEF1A1, H1-4 | MAPT 3704/4885TP53 4346/4885CA1 866/4885 |
| US-20110294840-A1 | HYDRAZIDE COMPOUND AND USE OF THE SAME IN PEST CONTROL | H1-4, H1-2, H1-0 | MAPT 4590/4885TP53 4243/4885CA1 1099/4885 |
| US-20120029038-A1 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | H1-3, HRH4, EEF1A1 | MAPT 4028/4885TP53 4513/4885CA1 1006/4885 |
| US-20120035218-A1 | PEST CONTROL COMPOSITION | CTRL, CYP4F3, CYP4B1 | MAPT 4020/4885TP53 3378/4885CA1 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.